BioSpace News Archive

According to the global CRISPR And Cas Genes market size is expected to surpass around USD 9.85 billion by 2030 from valued at USD 2.09 billion in 2021 and growing at a CAGR of 17.60% from 2022 to 2030.

According to Nova one advisor, the global Head and Neck Cancer Drugs market size is expected to hit around USD 4.4 billion by 2030 from valued at USD 2.1 billion in 2021 and growing at a CAGR of 8.60% from 2022 to 2030. Rising surge in incidence of head and neck cancer worldwide is the vital factor escalating the head and neck cancer drug market growth.

According to Nova one advisor, the global Multiplex Detection Immunoassays market was valued at USD 1.8 billion in 2020 and it is expected to hit around USD 3.7 billion by 2030 with a CAGR of 9.7% during the forecast period 2022 to 2030.

AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access.

According to Nova one advisor, the global Molecular Diagnostics market was valued at USD 25.2 billion in 2022and it is expected to hit around USD 47.9 billion by 2030 with a CAGR of 14.1% during the forecast period 2022 to 2030.

According to Nova one advisor, the global Neurology Clinical Trials market was valued at USD 6.1 billion in 2021 and it is expected to hit around USD 10.7 billion by 2030 with a CAGR of 5.9% during the forecast period 2022 to 2030.

According to Nova one advisor, the global Medical Enzyme Technology market was valued at USD 4.7 billion in 2021 and it is expected to hit around USD 7.9 billion by 2027 with a CAGR of 6.2% during the forecast period 2022 to 2030.

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”) today presented preclinical data for its two lead RAS programs – a next-generation KRASG12C dual inhibitor program and a novel PI3Kα:RAS breaker program – in an oral presentation at the Fourth RAS Initiative Symposium in Frederick, MD. BridgeBio will also be hosting an investor call at 1:30 ET today to discuss the data.

iCRYO, the fast-growing recovery and wellness brand, recently recognized their top-performing franchisees at the company’s 1st Annual Elevate Conference that took place in League City, Texas from September 22nd to the 25th.

Elixir Medical , a developer of innovative, drug-eluting cardiovascular devices, today announced it has appointed Alexey (Alex) Nepogodiev as Executive Vice President, Global Marketing.